COMMUNIQUÉS West-GlobeNewswire
 
      -   
  Sienna Biopharmaceuticals to Present at BAML Health Care Conference11/05/2018
-   
  Milestone Scientific Schedules First Quarter 2018 Conference Call11/05/2018
-   
  ICC Labs Receives Organic Hemp Certification, Readies for Harvest and Continues Construction of Laboratory11/05/2018
-   
  Teladoc to Participate in Upcoming Investor Conferences11/05/2018
-   
  Scythian Biosciences Announces Binding Agreement for Argentinian Acquisition of ABP11/05/2018
-   
  T1D Exchange Co-Founder Dana Ball to Step Down as CEO11/05/2018
-   
  Cerner to Hold 2018 Shareholder Meeting May 1811/05/2018
-   
  Progressive Care Inc. Selects CMW Media as New Public Relations Agency of Record11/05/2018
-   
  Cerecor Reports First Quarter 2018 Financial Results11/05/2018
-   
  Abeona Therapeutics Reports First Quarter 2018 Financial Results and Business Highlights11/05/2018
-   
  Vital Therapies to Host Analyst R&D Day on May 24, 201811/05/2018
-   
  Cellectar Reports Recent Corporate Highlights and 2018 First Quarter Financial Results11/05/2018
-   
  Samumed Announces Presentation at the 2018 American Thoracic Society (ATS) International Conference11/05/2018
-   
  Denali Therapeutics Reports First Quarter 2018 Financial Results11/05/2018
-   
  Spectral Announces First Quarter Results11/05/2018
-   
  Savara to Present at Bank of America Merrill Lynch 2018 Healthcare Conference on May 17th11/05/2018
-   
  Theratechnologies Announces That National Institutes of Health Will Support Study on EGRIFTA® (Tesamorelin for Injection) in Non-HIV Patients With Non-Alcoholic Fatty Liver Disease11/05/2018
-   
  Theratechnologies annonce que les National Institutes of Health appuieront une étude avec EGRIFTA(MD) (tésamoréline pour injection) chez des patients séro-négatifs atteints de stéatose hépatique non alcoolique11/05/2018
-   
  Melinta Therapeutics Launches New Antibiotic Stewardship Program to Combat Growing Threat of Antimicrobial Resistance11/05/2018
Pages